ADVI Health’s director of strategic analytics, value and economics (SAVEs), Ashis Das, was recently featured in HMP Global Learning Network’s First Report Managed Care.

In the article, “How the IRA Is Reshaping Drug Evaluation Through Medicare-Focused Real-World Evidence,” that was published on December 4, Ashis expands on how the Centers for Medicare & Medicaid Services (CMS) is redefining “value,” the growing influence of real-world effectiveness and adherence data, and what manufacturers and payers must do to meet rising expectations.

Read the full article in First Report Managed Care.